Proposing a Profit Cap and Price Control Scheme to Achieve Smoke-Free 2030 Ambition

 
Establishing a
Smoke-free 2030
Fund
 
Dr Henry Featherstone
Policy Advisor
 
W
h
a
t
s
 
t
h
e
 
p
r
o
b
l
e
m
?
 
Without much faster declines in smoking UK Government's Smoke-
free 2030 ambition won’t be achieved in the most deprived
communities until 2045:
450,000 households and 260,000 children in tobacco poverty
 
Pre-Covid government promised to consider a US style ‘polluter pays’
approach to funding tobacco control
Public health measures chronically under funded pre-Covid.
 
Covid saw Government borrow £303 billion (14.5% of GDP) in 2020-
2021:
Post-Covid new sources of funding for tobacco control essential
 
Tobacco company oligopoly in the UK market with estimated profits
of £900M and margins of up to 70%:
 Companies ‘over-shifting’ by increasing prices alongside excise duty escalator
 
 
 
W
h
a
t
 
c
o
u
l
d
 
b
e
 
d
o
n
e
?
 
Pharmaceutical company profits on the sale of branded medicines to
the NHS are heavily regulated, with repayment to DHSC:
Profit control scheme in operation since 1957
Typical repayment £560M per annum
 
DHSC has expertise in monitoring company profits & closing
loopholes through evolution of the pharmaceutical scheme:
Specific allowances encourage desired behaviour e.g. innovation and R&D
 
Brexit gives UK Government freedom to set tobacco prices:
Excise duty and VAT currently make up ~90% of tobacco price
 
P
r
o
f
i
t
 
c
a
p
 
&
 
p
r
i
c
e
 
c
o
n
t
r
o
l
 
s
c
h
e
m
e
 
f
o
r
 
t
o
b
a
c
c
o
 
The objectives of the proposed scheme are:
 
1.
To control the market power and limit the profits of tobacco
companies operating in the UK
Annual Financial Return for top 4 tobacco companies
Suggested 10% profit for tobacco companies, whereas 17-21% for pharma
Implemented as simple sales-based levy
 
2.
Shift tobacco company behaviour to focus on e-cigarettes and
vaping products
Need to ensure exemptions don’t  distort new markets
 
3.
Raise funds to fund the Smoke-free 2030 ambition, plus other
public health initiatives
Could raise £700M: Smoke-free 2030 fund £315M p.a.,
£385M ‘surplus’ for public health initiatives
 
W
h
a
t
 
s
h
o
u
l
d
 
h
a
p
p
e
n
 
n
e
x
t
?
 
Forthcoming NHS Bill would require just 10 paragraphs of primary
legislation to give the SoS profit & pricing powers over the tobacco
industry:
Public support for producer ‘polluter pays’ approach with tobacco
 
Secondary legislation could be designed & refined with DHSC
expertise and learnings from the pharmaceutical scheme:
Important information gathering powers e.g. cost of goods, distribution
Publication in aggregate form for Parliamentary Committee review
 
New Office for Health Promotion in DHSC would be key organisation
to oversee administration of Smoke-free 2030 Fund:
Consider how to fund the post-2030 position
Slide Note
Embed
Share

To achieve the UK Government's Smoke-Free 2030 ambition in the most deprived communities by 2045, it is crucial to implement a profit cap and price control scheme for tobacco companies. This scheme aims to limit tobacco company profits, shift focus to e-cigarettes, raise funds for public health initiatives, and oversee administration through the new Office for Health Promotion in DHSC.

  • Smoke-Free 2030
  • Tobacco Control
  • Profit Cap
  • Price Control
  • Public Health

Uploaded on Sep 12, 2024 | 0 Views


Download Presentation

Please find below an Image/Link to download the presentation.

The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. Download presentation by click this link. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.

E N D

Presentation Transcript


  1. Establishing a Smoke-free 2030 Fund Dr Henry Featherstone Policy Advisor

  2. Whats the problem? What s the problem? Without much faster declines in smoking UK Government's Smoke- free 2030 ambition won t be achieved in the most deprived communities until 2045: 450,000 households and 260,000 children in tobacco poverty Pre-Covid government promised to consider a US style polluter pays approach to funding tobacco control Public health measures chronically under funded pre-Covid. Covid saw Government borrow 303 billion (14.5% of GDP) in 2020- 2021: Post-Covid new sources of funding for tobacco control essential Tobacco company oligopoly in the UK market with estimated profits of 900M and margins of up to 70%: Companies over-shifting by increasing prices alongside excise duty escalator

  3. What could be done? What could be done? Pharmaceutical company profits on the sale of branded medicines to the NHS are heavily regulated, with repayment to DHSC: Profit control scheme in operation since 1957 Typical repayment 560M per annum DHSC has expertise in monitoring company profits & closing loopholes through evolution of the pharmaceutical scheme: Specific allowances encourage desired behaviour e.g. innovation and R&D Brexit gives UK Government freedom to set tobacco prices: Excise duty and VAT currently make up ~90% of tobacco price

  4. Profit cap & price control scheme for tobacco Profit cap & price control scheme for tobacco The objectives of the proposed scheme are: 1. To control the market power and limit the profits of tobacco companies operating in the UK Annual Financial Return for top 4 tobacco companies Suggested 10% profit for tobacco companies, whereas 17-21% for pharma Implemented as simple sales-based levy 2. Shift tobacco company behaviour to focus on e-cigarettes and vaping products Need to ensure exemptions don t distort new markets 3. Raise funds to fund the Smoke-free 2030 ambition, plus other public health initiatives Could raise 700M: Smoke-free 2030 fund 315M p.a., 385M surplus for public health initiatives

  5. What should happen next? What should happen next? Forthcoming NHS Bill would require just 10 paragraphs of primary legislation to give the SoS profit & pricing powers over the tobacco industry: Public support for producer polluter pays approach with tobacco Secondary legislation could be designed & refined with DHSC expertise and learnings from the pharmaceutical scheme: Important information gathering powers e.g. cost of goods, distribution Publication in aggregate form for Parliamentary Committee review New Office for Health Promotion in DHSC would be key organisation to oversee administration of Smoke-free 2030 Fund: Consider how to fund the post-2030 position

Related


More Related Content

giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#